deadiversion.usdoj.govDiversion Control Division | Welcome

- DEA.Registration.Help@dea.gov 1.800.882.9539 HomeProgram Description Customer Service Plan DEA Forms & Applications Mailing Addresses Meeting & Events Privacy Notice What’s New Registration Registration CMEA Required Training & Self-Certification Quota Applications Marihuana Growers Information Notice of Registration Reporting ARCOS BCM Online Chemical Import/Export Declarations CSOS Theft/Loss Reporting Import/Export Medical Missions Quotas Registrant Record of Controlled Substances Destroyed Regulated Machines (Tableting and Encapsulating) Reports Required by 21 CFR SORS Submit a Tip to DEA Year-end Reports Resources Administrative Actions Chemical Control Program CMEA (Combat Meth Epidemic Act) Controlled Substances Schedules DEA Regulatory Priorities DEA TOX Drug Disposal Information Drug & Chemical Information EPCS (Electronic Prescriptions for Controlled Substances) Federal Register Notices Guidance Document Portal Medications for Opioid Use Disorder National Prescription Drug Take Back Day NFLIS OPIOID (PHE) Information Publications & Manuals Questions & Answers Telemedicine Title 21 Code of Federal Regulations Title 21 USC Codified CSA Contact Us DATA-Waiver Waiver registration is no longer required to treat patients with opioid use disorder. LEARN MORE! Obtain or Renew DEA Registration Save Time, Apply Online CLICK HERE TO GET STARTED! DEA FORMS & APPLICATIONS NEED TO REGISTER, REPORT OR SUBMIT A TIP? OUR FORMS & APPLICATIONS WILL ASSIST YOU Year Round Pharmaceutical Disposal SEARCH FOR YEAR ROUND PHARMACEUTICAL DISPOSAL LOCATIONS CLICK HERE TO GET STARTED! INFORMATIONAL DOCUMENTS PUBLICATIONS & MANUALS CLICK HERE TO GET STARTED! Follow @DEA on Twitter LOOK FOR #DEADIVERSION CLICK HERE TO GET STARTED! CONTROLLED SUBSTANCE SCHEDULES REVIEW THE LIST OF CONTROLLED SUBSTANCES, EXEMPTED LISTS & DEFINITION OF CONTROLLED SUBSTANCE SCHEDULES CLICK HERE TO GET STARTED! Registration Forms &Applications Hours 8:30am–5:50pm ET Phone 1-800-882-9539 Email Email Us DEA Offices Find Local Office Contact Us Resources We are resolving an issue with the NFLIS DQS functionality. We anticipate the problem will be resolved soon. Multi-Factor Authentication added to the Registration Validation Toolset (PDF) (February 23, 2024) Provide feedback for the website redesign here: deadiversionwebmaster@dea.gov Quotas - Final Order: Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (PDF) - Welcome Registration Find official guidance on a variety Diversion Topics - Go to Registration Forms & Applications Find official guidance on a variety Diversion Topics - Go to Forms Questions & Answers Find official guidance on a variety Diversion Topics - Go to Q&A Meetings & Events Find official guidance on a variety Diversion Topics - Go to Meetings Guidance Documents Portal Find official guidance on a variety Diversion Topics - Go to Portal Drug Disposal Year-Round Disposal Sites Drug Take Back Day Disposal Methods - Go to Disposal Controlled Substance Schedules Schedules I-V Exempted Chemical List Exempted RX List - Go to Schedules Publications & Manuals Find official guidance on a variety Diversion Topics - Go to Pubs In The News Get Email Updates Get Email Updates × The United States Department of Justice You are now leaving a Department of Justice Web site. You are about to access: Email Updates The Department of Justice does not endorse the organizations or views represented by this site and takes no responsibility for, and exercises no control over, the accuracy, accessibility, copyright or trademark compliance or legality of the material contained on this site. Thank you for visiting our site. Close - View All February 20, 2024 Diversion News (PDF) - April 25, 2024 Anesthesiologist Pleads Guilty to Taking Fentanyl from Hospital April 23, 2024 New Haven Pharmacy and Owner Agree to Pay $120,000 to Settle Controlled Substances Act Allegations April 10, 2024 Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations April 8, 2024 Pill Distributor Pleads Guilty to Trafficking Tens of Thousands of Pills Containing Fentanyl and Meth April 3, 2024 Idaho Doctor Pays $96,000 to Settle Allegations That He Wrote Unlawful Prescriptions What’s New View All (May 9, 2024) Curia New York, Inc. (PDF) (May 9, 2024) Veranova, L.P. (PDF) (May 8, 2024) Wedgewood Village Pharmacy, LLC (PDF) (May 6, 2024) Pisgah Laboratories Inc. (PDF) (May 6, 2024) Entheogen Pharmaceuticals Inc. (PDF) (May 6, 2024) Lipomed (PDF) REGISTRATION REPORTING RESOURCES CONTACT US SITE MAP - PRIVACY NOTICE GET EMAIL UPDATES DEA.GOV JUSTICE.GOV USA.GOV REGULATIONS.GOV DOJ Privacy Policy Section 508 Accessibility DOJ Legal Policies & Disclaimers FOIA U.S. Department of Justice Drug Enforcement Administration DIVERSION CONTROL DIVISION 8701 Morrissette Drive Springfield, VA 22152 1.800.882.9539 NOTICE: Scheduled maintenance to our system will be performed on Saturday, February 18, 2023 from 7:00AM until 8:00PM. During this time, the Diversion Control Division Applications will not be available. We apologize for any inconvenience this may cause. Attention Registrants: DATA-Waived Registration Update...